← Back to patent-cliff list
CAS 60612-23-9
N-[(2-Chlorophenyl)methyl]-2-(thiophen-2-yl)ethan-1-amine hydrogen chloride
Codes: Ticlopidine-031
Application context (from source-drug indications)
Arterial occlusive diseaseTiclopidine Hydrochloride/Ginkgo Biloba Leaf Dried ExtractCerebrovascular diseaseTiclopidine Hydrochloride/Ginkgo Biloba Leaf Dried ExtractEmbolism and thrombosisTiclopidine Hydrochloride/Ginkgo Biloba Leaf Dried ExtractCarotid artery stenosisTiclopidine Hydrochloride/Ginkgo Biloba Leaf Dried ExtractThromboembolismTiclopidine HydrochlorideArterial occlusive diseaseTiclopidine HydrochlorideTransient ischaemic attackTiclopidine HydrochlorideIntracranial vasospasmTiclopidine HydrochlorideCerebrovascular diseaseTiclopidine HydrochlorideSubarachnoid haemorrhageTiclopidine Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Ticlopidine Hydrochloride/Ginkgo Biloba Leaf Dried Extract | Tier C — Watch / trade | - |
| Ticlopidine Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(2-Thienyl)ethyl 4-methylbenzenesulfonate→N-[(2-Chlorophenyl)methyl]-2-(thiophen-2-yl)ethan-1-amine hydrogen chloride→1,3-Dioxolane→2-(2-Hydroxyethyl)thiophene→1-(2-Chlorophenyl)methanamine
2-(2-Thienyl)ethyl 4-methylbenzenesulfonate→N-[(2-Chlorophenyl)methyl]-2-(thiophen-2-yl)ethan-1-amine hydrogen chloride→1,3-Dioxolane→2-(2-Hydroxyethyl)thiophene→1-(2-Chlorophenyl)methanamine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.